ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för eliprodil. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

24 träffar

Bibliografisk träff 2017-11-30

Evaluation of <sup>11</sup>C-Me-NB1 as a Potential PET Radioligand for Measuring GluN2B-Containing NMDA Receptors, Drug Occupancy, and Receptor Cross Talk.

Krämer SD, Betzel T, Mu L, Haider A, Herde AM, Boninsegni AK, Keller C, Szermerski M, Schibli R, Wünsch B, Ametamey SM.

J Nucl Med · research support, non-u.s. gov't; journal article · DOI 10.2967/jnumed.117.200451

Bibliografisk träff 2013-11-13

A pharmacological network for lifespan extension in Caenorhabditis elegans.

Ye X, Linton JM, Schork NJ, Buck LB, Petrascheck M.

Aging Cell · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1111/acel.12163

Bibliografisk träff 2004-08-09

Effect of a neuroprotective drug, eliprodil on cardiac repolarisation: importance of the decreased repolarisation reserve in the development of proarrhythmic risk.

Lengyel C, Dézsi L, Biliczki P, Horváth C, Virág L, Iost N, Németh M, Tálosi L, Papp JG, Varró A.

Br J Pharmacol · research support, non-u.s. gov't; research-article; journal article · DOI 10.1038/sj.bjp.0705901

Bibliografisk träff 2004-04-03

Administration of eliprodil during ethanol withdrawal in the neonatal rat attenuates ethanol-induced learning deficits.

Thomas JD, Garcia GG, Dominguez HD, Riley EP.

Psychopharmacology (Berl) · research support, u.s. gov't, p.h.s.; journal article · DOI 10.1007/s00213-004-1806-x

Bibliografisk träff 2000-06-01

Synthesis and resolution of racemic eliprodil and evaluation of the enantiomers of eliprodil as NMDA receptor antagonists.

Pabel J, Höfner G, Wanner KT.

Bioorg Med Chem Lett · research support, non-u.s. gov't; evaluation study; journal article · DOI 10.1016/s0960-894x(00)00246-8

Bibliografisk träff 1999-05-01

Protection by eliprodil against excitotoxicity in cultured rat retinal ganglion cells.

Pang IH, Wexler EM, Nawy S, DeSantis L, Kapin MA.

Invest Ophthalmol Vis Sci · research support, non-u.s. gov't; journal article

Bibliografisk träff 1999-05-01

Neuroprotective effects of eliprodil in retinal excitotoxicity and ischemia.

Kapin MA, Doshi R, Scatton B, DeSantis LM, Chandler ML.

Invest Ophthalmol Vis Sci · research support, non-u.s. gov't; journal article

Bibliografisk träff 1999-01-01

Eliprodil stimulates CNS myelination: new prospects for multiple sclerosis?

Demerens C, Stankoff B, Zalc B, Lubetzki C.

Neurology · research support, non-u.s. gov't; journal article · DOI 10.1212/wnl.52.2.346

Bibliografisk träff 1998-12-01

Place conditioning of mice with the NMDA receptor antagonists, eliprodil and dizocilpine.

Sukhotina I, Dravolina O, Bespalov A.

Eur J Pharmacol · comparative study; research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; journal article · DOI 10.1016/s0014-2999(98)00737-7

Bibliografisk träff 1998-07-01

Neuroprotective effect of eliprodil: attenuation of a conditioned freezing deficit induced by traumatic injury of the right parietal cortex in the rat.

Hogg S, Perron C, Barnéoud P, Sanger DJ, Moser PC.

J Neurotrauma · journal article · DOI 10.1089/neu.1998.15.545

Bibliografisk träff 1998-07-01

The effect of eliprodil on the evolution of a focal cerebral ischaemia in vivo.

Ibarrola D, Seegers H, Jaillard A, Hommel M, Décorps M, Massarelli R.

Eur J Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1016/s0014-2999(98)00330-6

Bibliografisk träff 1998-01-01

Eliprodil, a non-competitive, NR2B-selective NMDA antagonist, protects pyramidal neurons in hippocampal slices from hypoxic/ischemic damage.

Reyes M, Reyes A, Opitz T, Kapin MA, Stanton PK.

Brain Res · research support, non-u.s. gov't; journal article · DOI 10.1016/s0006-8993(97)01280-8

Bibliografisk träff 1997-11-01

Neuroprotection afforded by a combination of eliprodil and a thrombolytic agent, rt-PA, in a rat thromboembolic stroke model.

Lekieffre D, Benavides J, Scatton B, Nowicki JP.

Brain Res · journal article · DOI 10.1016/s0006-8993(97)00992-x

Bibliografisk träff 1997-10-01

Neuroprotective effects of eliprodil in a rat hippocampal slice hypoxia model.

Santamaria R, Françon D, Depoortere H, Scatton B.

Ann N Y Acad Sci · journal article · DOI 10.1111/j.1749-6632.1997.tb48433.x

Bibliografisk träff 1997-04-01

R- and L-type Ca2+ channels are insensitive to eliprodil in rat cultured cerebellar granule neurons.

Biton B, Godet D, Granger P, Avenet P.

Eur J Pharmacol · journal article · DOI 10.1016/s0014-2999(97)00141-6

Bibliografisk träff 1997-02-01

Antagonist properties of eliprodil and other NMDA receptor antagonists at rat NR1A/NR2A and NR1A/NR2B receptors expressed in Xenopus oocytes.

Avenet P, Léonardon J, Besnard F, Graham D, Depoortere H, Scatton B.

Neurosci Lett · journal article · DOI 10.1016/s0304-3940(97)13422-x

Bibliografisk träff 1996-03-01

The effects of ifenprodil and eliprodil on voltage-dependent Ca2+ channels and in gerbil global cerebral ischaemia.

Bath CP, Farrell LN, Gilmore J, Ward MA, Hicks CA, O'Neill MJ, Bleakman D.

Eur J Pharmacol · comparative study; journal article · DOI 10.1016/0014-2999(95)00846-2

Bibliografisk träff 1995-11-01

Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715).

Layer RT, Popik P, Olds T, Skolnick P.

Pharmacol Biochem Behav · journal article · DOI 10.1016/0091-3057(95)00155-p

Bibliografisk träff 1995-04-01

Influence of the rate of intravenous administration of eliprodil (SL 82.0715), a new anti-ischaemic agent, on its distribution in rat plasma and tissues.

Garrigou-Gadenne D, Thenot JP, Morselli PL.

J Pharmacokinet Biopharm · journal article · DOI 10.1007/bf02354269

Bibliografisk träff 1994-09-01

Lack of amnestic, psychotomimetic or impairing effect on psychomotor performance of eliprodil, a new NMDA antagonist.

Patat A, Molinier P, Hergueta T, Brohier S, Zieleniuk I, Danjou P, Warot D, Puech A.

Int Clin Psychopharmacol · comparative study; clinical trial; randomized controlled trial; journal article · DOI 10.1097/00004850-199409000-00003

Bibliografisk träff 1994-05-01

The NMDA receptor antagonist eliprodil (SL 82.0715) blocks voltage-operated Ca2+ channels in rat cultured cortical neurons.

Biton B, Granger P, Carreau A, Depoortere H, Scatton B, Avenet P.

Eur J Pharmacol · journal article · DOI 10.1016/0014-2999(94)90142-2

Bibliografisk träff 1993-08-01

Prevention by eliprodil (SL 82.0715) of traumatic brain damage in the rat. Existence of a large (18 h) therapeutic window.

Toulmond S, Serrano A, Benavides J, Scatton B.

Brain Res · journal article · DOI 10.1016/0006-8993(93)90267-q

Bibliografisk träff 1992-01-01

Pilot studies on the effect of SL 82.0715 in psychotic syndromes.

Garreau M, Giroux C, L'Heritier C, Coupez M, Eich F, Morselli PL.

Clin Neuropharmacol · journal article · DOI 10.1097/00002826-199201001-00361

Bibliografisk träff 1988-12-01

Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. I. Evidence for efficacy in models of focal cerebral ischemia.

Gotti B, Duverger D, Bertin J, Carter C, Dupont R, Frost J, Gaudilliere B, MacKenzie ET, Rousseau J, Scatton B.

J Pharmacol Exp Ther · journal article · DOI 10.1016/s0022-3565(25)13281-3